Published in TB and Outbreaks Week, February 2nd, 1998
"(Our) study establishes the role of ethambutol in improving therapy for MAC bacteremia by reducing relapses, emergence of clarithromycin resistance, and febrile morbidity," researcher Michael P. Dube and colleagues wrote ("A Randomized Evaluation of Ethambutol for Prevention of Relapse and Drug Resistance During Treatment of Mycobacterium avium Complex Bacteremia with Clarithromycin-Based Combination Therapy," Journal of Infectious Diseases, November...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week